CDT Equity

CDT Equity Liabilities

The The Liabilities of CDT Equity (CDT) as of Oct 17, 2026 is 2.28 B USD. In the previous year, The Liabilities was 10.99 M USD — a change of 20,646.38% (higher).

Liabilities

2.28 BUSD

YoY

20,646.38%

Last updated:

In 2025, CDT Equity's total liabilities amounted to 2.28 B USD, a 20,646.38% difference from the 10.99 M USD total liabilities in the previous year.

The CDT Equity Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2021
192,506.00 USD
Jan 1, 2022
10.09 M USD
Jan 1, 2023
7.68 M USD
Jan 1, 2024
10.99 M USD
Jan 1, 2025
2.28 B USD
The CDT Equity Liabilities history
YEARLiabilitiesYoY
2.28 BUSD+20,646.38%
10.99 MUSD+43.03%
7.68 MUSD-23.91%
10.09 MUSD+5,143.47%
192,506.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CDT Equity Stock analysis

What does CDT Equity do? CDT Equity Inc, headquartered in San Diego, US, operates in the Health Care sector within Life Sciences Tools & Services. The company focuses on developing and commercializing clinical assets for unmet medical needs, including treatments for idiopathic male infertility, autoimmune diseases, and conditions like uveitis, preterm labor, and renal transplant rejection. Its pipeline features AZD1656, a glucokinase activator for diabetes, and AZD5904, a myeloperoxidase inhibitor targeting idiopathic male infertility. Listed on February 3, 2022, the firm is disease-agnostic in its approach. CDT Equity is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing CDT Equity's Liabilities

CDT Equity's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating CDT Equity's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing CDT Equity's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

CDT Equity's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in CDT Equity’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about CDT Equity stock

The Liabilities of CDT Equity is 2.28 B USD in 2025.

The Liabilities of CDT Equity changed from 10.99 M USD to 2.28 B USD, representing a 20,646.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities CDT Equity since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's CDT Equity historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — CDT Equity

All Key Metrics — CDT Equity